Market closed

Sanara MedTech/SMTI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Sanara MedTech

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Ticker

SMTI
Trading on

Industry

Health Care Equipment & Supplies

Employees

108

Sanara MedTech Metrics

BasicAdvanced
$272M
Market cap
-
P/E ratio
-$0.78
EPS
1.59
Beta
-
Dividend rate
$272M
1.59
$43.25
$26.00
26K
1.799
1.449
38.365
39.316
-5.02%
-6.61%
-16.23%
3.613
6.53
-55.9
-83.317
21.42%
-25.72%
52.59%
11.10%

What the Analysts think about Sanara MedTech

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Sanara MedTech stock.

Sanara MedTech Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy SMTI

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sanara MedTech stock?

Sanara MedTech (SMTI) has a market cap of $272M as of October 12, 2024.

What is the P/E ratio for Sanara MedTech stock?

The price to earnings (P/E) ratio for Sanara MedTech (SMTI) stock is 0 as of October 12, 2024.

Does Sanara MedTech stock pay dividends?

No, Sanara MedTech (SMTI) stock does not pay dividends to its shareholders as of October 12, 2024.

When is the next Sanara MedTech dividend payment date?

Sanara MedTech (SMTI) stock does not pay dividends to its shareholders.

What is the beta indicator for Sanara MedTech?

Sanara MedTech (SMTI) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.